The Protein Expression Market size in North America was worth USD 848.14 Million in 2021 and is estimated to be growing at a CAGR of 7.36% to reach USD 1209.71 Million by 2026.
Protein expression is the process of altering, synthesizing, and controlling the proteins in living organisms. Proteins are controlled and manufactured depending upon the practical need in the host cell. Biotechnology-based companies create novel therapeutics with negligible side effects, thereby generating a huge market for Protein expression.
Factors such as an increase in the pharma division’s research and development movement, prospects in proteomics, rising rates of chronic diseases, and government initiatives drive the expansion of the North American protein expression market. In addition, market growth is expected to be aided by growth in the biologics market.
The increasing support from private and public organizations through biotechnology investments is surely a crucial driver driving the North America protein expression market demand. Market demand is also being accelerated by an increase in the number of research institutes in the biosciences industry. In addition, the rising prevalence of successful treatment approaches is having a substantial impact on market growth.
The rising prevalence of chronic disorders across the region is expected to propel the market forward. Furthermore, as people become more aware of the negative consequences of molecular drugs, they are turning to biologics, boosting the demand for protein expression. The continued investment in genomics and proteomics by manufacturers and government is projected to generate attractive prospects for the protein expression industry to develop in the future years.
However, The market’s expansion is being hampered by expensive product development costs and a complex regulatory environment. Over the projection period, the high cost of protein expression systems and the absence of effective techniques for post-translational modifications are projected to limit the market growth.
This research report on the North America Protein Expression Market has been segmented and sub-segmented into the following categories:
By Expression Systems:
Yeast Expression
Insect Expression
Cell-Free Expression
Bacterial Expression
Algal Expression
Mammalian Expression
By-Products:
Reagents
Services
Instruments
Others
By Application:
Industrial Proteins
Cell Culture
Research
Therapeutic Proteins
Transfection Technologies
Others
By End User:
Biotechnology
Pharmaceutics
Academia
By Country:
The United States
Canada
Rest of North America
Geographically, North America protein expression market is leading with a large share. The increase in capital income in both developed and emerging countries is attributed to boosting market demand. In addition, pharmaceutical companies increased vaccines and antibody manufacturing rates are projected to outshine the market demand. According to the American Cancer Society’s January 2021 report, there will be an expected 1,898,160 new cancer cases, with 608,570 individuals dying from it. The growing need for gene and monoclonal antibody-based therapies in treating diseases including cancer, rare diseases, and other disorders is also propelling the North American protein expression market in the area.
On the other hand, the United States dominated the North America protein expression market, and it is more likely to continue its dominance throughout the forecast period. The US accounts for over 70% of the whole market region. The market growth is driven by increasing investments in research, rising usage of protein technology, and the rapidly evolving pharmaceutical industries. Another factor driving the market in the United States is the presence of many companies within the country. In addition, in the United States, opportunities in the field of proteomics have boosted the market even further.
According to Statistics Canada’s “The Canadian Research and Development Pharmaceutical Sector” report from May 2021, the pharmaceutical sector contributed nearly USD 15 billion in value to the Canadian economy in 2018 while spending between USD 1.5 billion and USD 2 billion on research and development. The market is rising due to a growing patient population and increased research and development spending in the region.
Companies playing a dominant role in the North America Protein Expression Market profiled in this report are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Expression System
5.1.1 Yeast Expression
5.1.2 Insect Expression
5.1.3 Cell-Free Expression
5.1.4 Bacterial Expression
5.1.5 Algal Expression
5.1.6 Mammalian Expression
5.2 By Product
5.2.1 Reagents
5.2.2 Services
5.2.3 Instruments
5.2.4 Others
5.3 By Application
5.3.1 Industrial Proteins
5.3.2 Cell Culture
5.3.3 Research
5.3.4 Therapeutic Proteins
5.3.5 Transfection technologies
5.3.6 Others
5.4 By End User
5.4.1 Biotechnology
5.4.2 Pharmaceutics
5.4.3 Academia
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Life Technologies Corporation
8.3 Bio-Rad Laboratories
8.4 New England BioLabs
8.5 Merck Millipore
8.6 Takara Bio
8.7 Thermo Fisher Scientific
8.8 Promega Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
11. Appendix
a) List of Tables
b) List of Figures
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environmentGlobal Medical Aesthetics Devices Market, Medical Aesthetics Devices Market research report, Medical Aesthetics Devices industry analysis
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Related Reports
Apr 2021
